However, this increase in VEGF and vessels in the present article was the opposite of that previously found in a neoplasia model where M14 cells treated with the inhibitor PD0325901 resulted in a significant and dose-dependent inhibition of VEGF release [41]. This evidence concerns the gene VEGFA and neoplasm.